Drug · DIN 02518015
APO-ELETRIPTAN TABLETS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 1, 2022; first marketed June 1, 2022.
- Drug Identification Number (DIN)
- 02518015
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Eletriptan N02CC06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELETRIPTAN (ELETRIPTAN HYDROBROMIDE) | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 15, 2021: NOC 26268Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named APO-ELETRIPTAN TABLETS
- DIN 02518023 · Marketed